McKesson's Fourth-quarter Earnings Beat Forecasts

McKesson Corp. said Tuesday fourth-quarter net income was $132 million, or 56 cents per diluted share, compared with $370 million, or $1.58 a share for the same period a year ago. Sales for the San Francisco-based drug distribution giant were $44.9 billion against the $37.8 billion from a year ago. Adjusted income was $2.94 a share, ahead of the $2.74 forecast from analysts polled by FactSet. Revenue was expected to reach $45.04 billion. The company said it sees 2016 earnings coming in at $12.20 to $12.70 a share, in line with the $12.57 FactSet forecast. McKesson shares ended trading Tuesday up marginally to $229.55 a share, but added more than 1% after the close to $230.59.